Stay updated on Idasanutlin Combo in AML: Clinical Trial

Sign up to get notified when there's something new on the Idasanutlin Combo in AML: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idasanutlin Combo in AML: Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    No significant changes to core study content were observed; any differences appear limited to minor layout or metadata updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T01:24:23.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    1%
    Check dated 2025-10-05T10:12:50.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added revision label v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) as well as the earlier v3.0.2 deletion, indicating a shift in content focus and an updated versioning.
    Difference
    0.2%
    Check dated 2025-09-28T03:16:11.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Updated to Revision v3.0.2, replacing the old v3.0.1; removed the 'Back to Top' element as a minor UI cleanup.
    Difference
    0.1%
    Check dated 2025-09-13T17:17:44.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T15:01:13.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations across various countries, as well as the introduction of new drug-related terms. Notably, the content related to acute myeloid leukemia has been retained, while several previous terms and locations have been removed.
    Difference
    8%
    Check dated 2025-08-30T11:47:58.000Z thumbnail image

Stay in the know with updates to Idasanutlin Combo in AML: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo in AML: Clinical Trial page.